COVAXIN – Bharat Biotech announces phase 3 results, 81% efficacy of admin March 4, 2021March 4, 2021 Banner Slider Delhi News top horizontal scroller Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of its BBV152 (COVAXIN). It is...